ATC Group: N03AG Fatty acid derivatives

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N03AG in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N03 Antiepileptics
3 N03A Antiepileptics
4 N03AG Fatty acid derivatives

Group N03AG contents

Code Title
N03AG01 Valproic acid
N03AG02 Valpromide
N03AG03 Aminobutyric acid
N03AG04 Vigabatrin
N03AG05 Progabide
N03AG06 Tiagabine

Active ingredients in N03AG

Active Ingredient Description
Tiagabine

Tiagabine is an anti-epileptic drug. Tiagabine is a potent and selective inhibitor of both neuronal and glial GABA uptake, which results in an increase in GABAergic medicated inhibition in the brain.

Valproic acid

Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.

Valpromide
Vigabatrin

Vigabatrin is a selective irreversible inhibitor of GABA transaminase, the enzyme responsible for the breakdown of GABA (gamma aminobutyric acid). Vigabatrin increases the concentration of GABA, the major inhibitory neurotransmitter in the brain.

Related product monographs

Title Information Source Document Type  
CONVULEX Gastro-resistant capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DEPAKENE Oral solution Health Products and Food Branch (CA) MPI, CA: SPM
DEPAKINE CHRONO Prolonged-release tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
EPILIM CHRONOSPHERE Modified release granules Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
EPILIM Powder and solvent for solution for injection / infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
EPIVAL Prolonged-release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
GABITRIL Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
KIGABEQ Soluble tablet European Medicines Agency (EU) MPI, EU: SmPC
RUBILIM Prolonged release tablet Health Products Regulatory Authority (ZA) MPI, Generic
SABRIL Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VIGAFYDE Oral solution MPI, US: SPL/PLR